RecruitingNCT07351916

Remission in Adults With Mild-to-moderate Asthma in Thailand


Sponsor

Thammasat University

Enrollment

289 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to determine the prevalence of remission among adults with mild-to-moderate asthma, as well as the factors associated with remission in Thailand. The main question the study aims to answer is: What is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete a questionnaire on asthma symptoms and undergo pulmonary function testing and a blood test once.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • mild-to-moderate asthma
  • age 18 years or older

Exclusion Criteria1

  • inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERGlobal Initiative for Asthma (GINA) and Asthma Control Test (ACT) questionnaires

GINA and ACT are questionnaires used to assess the level of asthma control.

OTHERSpirometry

Spirometry is a tool used to assess pulmonary function.

OTHERFractional exhaled nitric oxide (FeNO) test

FeNO is a tool used to assess eosinophilic airway inflammation and asthma remission.

OTHERBlood eosinophil count (BEC)

BEC is a tool used to assess eosinophilic inflammation and asthma remission.


Locations(2)

Narongkorn Saiphoklang

Pathum Thani, Changwat Pathum Thani, Thailand

Faculty of Medicine, Thammasat University

Pathum Thani, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07351916


Related Trials